Secondary Schizophrenia (164 page)

(1985). Relapse Prevention:

antipsychotic withdrawal in

review. Fortsch Neurol Psychiatr,

Maintenance Strategies in the

schizophrenia. Compr Psychiatry,

2005.
73
:728–35.

Treatment of Addictive Behaviors.

2002.
43
:393–6.

55. Steinberg M. L., Ziedonis D. M.,

New York: Guilford Press.

72 Dopke C. A., Lehner R. K., Wells

Krejci J. A.,
et al.
Motivational

63. McGovern M. P., Wrisley B. R.,

A. M. Cognitive-behavioral group

interviewing with personalized

Drake R. E. Relapse of substance

therapy for insomnia in

feedback: A brief intervention for

use disorder and its prevention

individuals with serious mental

motivating smokers with

among persons with co-occurring

illnesses: a preliminary

schizophrenia to seek treatment

disorders. Psychiatr Serv, 2005.

evaluation. Psychiatr Rehabil J,

for tobacco dependence. J Consult

56
:1270–3.

2004.
27
:235–42.

Clin Psychol, 2004.
72
:723–8.

64. Xie H., Drake R. E., McHugo G. J.

73. Biancosino B., Rocchi D., Donà S.,

56. Osher F. C., Kofoed L. L.

Are there distinctive trajectory

et al.
Efficacy of a short-term

Treatment of patients with

groups in substance abuse

psychoeducational intervention

psychiatric and psychoactive

remission over 10 years? An

for persistent non-organic

substance use disorders. Hosp

application of the group-based

insomnia in severely mentaly ill

Community Psychiatry, 1989.

modeling approach. Adm Policy

patients. Eur Psychiatr, 2006.

40
:1025–30.

Ment Health, 2006.
33
:423–
21
:460–2.

57. Morse G. A., Calsyn R. J.,

32.

74. Smith M. T., Huang M. I., Manber

Klinkenberg D. W.,
et al.
Treating

65. Hunt G. M., Azrin N. H. A

R. Cognitive behavior therapy for

homeless clients with severe

community-reinforcement

chronic insomnia occurring

mental illness and substance use

approach to alcoholism. Behav Res

within the context of medical and

disorders: costs and outcomes.

Ther, 1973.
11
:91–104.

psychiatric disorders. Clin Psychol

Community Ment Health J, 2006.

Rev, 2005.
25
:559–92.

42
:377–404.

66. Pourmand D., Kavanagh D. J.,

Vaughan K. Expressed emotion as

75. Jacobs G. D., Pace-Schott E. F.,

58. Haddock G., Barrowclough C.,

predictor of relapse in patients

Stickgold R.,
et al.
Cognitive

Tarrier N.,
et al.

with comorbid psychoses and

behavior therapy and

Cognitive-behavioural therapy

substance use disorder. Aust NZ J

pharmacotherapy for insomnia.

and motivational intervention for

Psychiatry, 2005.
39
:473–8.

Arch Intern Med, 2004.

schizophrenia and substance

164
:1888–96.

misuse: 18-month outcomes of a

67. Kavanagh D. J., Sitharthan G.,

randomised controlled trial. Br J

Young R. M.,
et al.
Addition of cue

76. Wehr T. A., Turner E. H., Shimada

Psychiatry, 2003.
183
:418–26.

exposure to cognitive-behaviour

J. M.,
et al.
Treatment of a rapidly

therapy for alcohol misuse: a

cycling bipolar patient by using

59. Donald M., Dower J., Kavanagh

randomized controlled trial with

extended bed rest and darkness to

D. J. Integrated versus

dysphoric drinkers. Addiction,

stabilise the timing and duration

nonintegrated management and

2006.
101
:1106–16.

of sleep. Biol Psychiatry, 1998.

care for clients with co-occurring

43
:822–8.

mental health and substance use

68. Rapp C. A. (1998). The Strengths

disorders: A qualitative systematic

Model: Case Management with

77. Morgenthaler T., Kramer M.,

review of randomised controlled

People Suffering from Severe and

Alessi C.,
et al.
Practice

trials. Soc Sci Med, 2005.

Persistent Mental Illness. New

parameters for the psychological

60
:1371–83.

York: Oxford University Press.

and behavioral treatment of

insomnia: an update. An

60. Mueser K. T., Crocker A. G.,

69. Oades L. G., Deane F. P., Crowe T.

American Academy of Sleep

Frisman L. B.,
et al.
Conduct

P.,
et al.
Collaborative Recovery:

Medicine Report. Sleep 2006.

disorder and antisocial

an integrative model for working

29
:1415–19.

personality disorder in persons

with individuals that experience

with severe psychiatric and

chronic or recurring mental

78. Pilling S., Bebbington P., Kuipers

substance use disorders. Schizophr

illness. Australas Psychiatry, 2005.

E.,
et al.
Psychological treatment

Bull, 2006.
32
:626–36.

13
:279–84.

in schizophrenia: I. Meta-analysis

Treatment – Section 5

of family interventions and

schizophrenia. Am J Psychiatry,

Practical Handbook, Kavanagh

cognitive behavior therapy.

2002. 159:1653–64.

D. J. (Ed). London: Chapman &

Psychol Med, 2002.
32
:763–

Hall, pp. 45–58.

87. Kemp R., Hayward P.,

82.

Applewhaite G.,
et al.
Compliance

96. Delahunty A., Morice R.

79. Gaudiano B. A. Cognitive

therapy in psychotic patients:

Rehabilitation of frontal/executive

behavior therapies for psychotic

randomised controlled trial.

impairments in schizophrenia.

disorders: current empirical status

Br Med J, 1996.
312
:345–9.

Aust NZ J Psychiatry, 1996.

and future directions. Clin Psychol

30
:760–7.

88. Boczkowski J. A., Zeichner A.,

Sci Prac, 2005.
12
:33–50.

DeSanto N. Neuroleptic

97. Kavanagh D. J. Recent

80. Zimmerman G., Favrod J., Trieu

compliance among chronic

developments in expressed

V. H.,
et al.
The effect of cognitive

schizophrenic outpatients: an

emotion and schizophrenia. Br J

behavioral treatment on the

intervention outcome report.

Psychiatry, 1992.
160
:601–20.

positive symptoms of

J Consult Clin Psychol, 1985.

98. Kavanagh D. (1992). Family

schizophrenia spectrum

53
:666–71.

interventions in schizophrenia. In

disorders: a meta-analysis.

Schizophrenia: an Overview and

Schizophr Res, 2005.
77
:1–9.

89. Cramer J. A., Rosenheck R.

Enhancing medication

Practical Handbook, Kavanagh D.

81. Pfammatter M., Junghan U. M.,

compliance for people with

J. (Ed). London: Chapman & Hall,

Brenner H. D. Efficacy of

serious mental illness. J Nerv Ment

pp. 407–23.

psychological therapy in

Dis, 1999.
187
:53–5.

99. Lehman A. F., Herron J. D.,

schizophrenia: conclusions from

Schwartz R. P.,
et al.

meta-analyses. Schizophr Bull,

90. Bellack A. S. Skills training for

Rehabilitation for adults with

2006.
32
(Suppl 1):S64–S80.

people with severe mental illness.

Psychiatr Rehabil J, 2004.

severe mental illness and

82. Kingdon A., Turkington D.

27
:375–91.

substance use disorders: a clinical

(1994). Cognitive-Behavioral

trial. J Nerv Ment Dis, 1993.

Therapy of Schizophrenia. Hove,

91. Kopelowicz A., Liberman R. P.,

181
:86–90.

UK: Lawrence Erlbaum.

Zarate R. Recent advances in

100. Hellerstein D. J., Rosenthal R. N.,

social skills training for

83. Trower P., Birchwood M., Meaden

Miner C. R. Integrating services

schizophrenia. Schizophr Bull,

A.,
et al.
Cognitive therapy for

for schizophrenia and substance

2006.
32
(Suppl 1):S12–S23.

command hallucinations:

abuse. Psychiatr Q, 2001.

randomized controlled trial. Br J

92. Kurtz M. M., Mueser K. T.

72
:291–306.

Psychiatry, 2004.
184
:312–20.

A meta-analysis of controlled

101. Herman S. E., Frank K. A.,

research on social skills training

84. Kuipers E., Garety P., Fowler D., et

Mowbray C. T.,
et al.
Longitudinal

for schizophrenia. J Consult Clin

al. Cognitive, emotional, and

effects of integrated treatment on

Psychol, 2008.
76
:491–504.

social processes in psychosis:

alcohol use for persons with

refining cognitive behavioral

93. Mueser K. T., Penn D. L.

serious mental illness and

therapy for persistent positive

Correspondence. Psychol Med,

substance use disorders. J Behav

symptoms. Schizophr Bull, 2006.

2004. 1365–7.

Health Serv Res, 2000.
27
:286–302.

32
(Suppl 1):S24–S31.

94. Pilling S., Bebbington P., Kuipers

102. Baker A., Lewin T., Reichler H.,

85. Donohue G. Adherence to

E.,
et al.
Psychological treatments

et al.
Motivational interviewing

antipsychotic treatment in

in schizophrenia: II.

among psychiatric in-patients

schizophrenia: what role does

Meta-analyses of randomized

with substance use disorders. Acta

cognitive behavioral therapy play

controlled trials of social skills

Psychiatr Scand, 2002.

in improving outcomes? Dis

training and cognitive

106
:233–40.

Manage Health Outcomes, 2006.

remediation. Psychol Med, 2004.

103. Hulse G. K., Tait R. J. Five-year

14
:207–14.

32
:783–91.

outcomes of a brief psychiatric

86. Zygmunt A., Olfson M., Boyer C.

95. Green M. F. (1992). Information

intervention for adult in-patients

A.,
et al.
Interventions to improve

processing in schizophrenia. In

with psychiatric disorders.

medication adherence in

Schizophrenia: An Overview and

Addiction, 2003.
98
:1061–8.

418

δ
-9-tetrahydrocannabinol (
δ
-THC),

adenosine triphosphate binding

and acute psychotic disorder,

114

cassette (ABC),
243

381–
2

and antipsychotic medications,

κ
opioids,
107

adrenoleukodystrophy (ALD),
220–
1,

394

1H (Proton) MRS,
7

243

diagnostic tests,
244

and genetics of schizophrenia,